Acesion Pharma

Acesion, targeting first new approach to AF in decades, hits primary endpoint in midphase trial
Fierce Biotech
Tue, 03/14/23 - 11:09 am
Acesion Pharma
atrial fibrillation
clinical trials
AP30663